Analyst Consensus ?
ConsensusBuy44 ratings
Bullish2863.6%
Neutral1636.4%
Bearish00.0%
Johnson Controls International plc · JCI · FY2026 Q4 · Calendar Q4 2026
JCI: Record backlog supports FY2027 growth outlook
Management's maintained FY2027 outlook is supported by record backlog and data-center demand, while execution, supply-chain, and demand risks remain.
Reported Before market openNYSEBasic Materials
$89.35B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.59
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $7.04B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+5.7%
Event window
SPY move
+0.6%
Same window
Abnormal move
+5.1%
Stock minus SPY
Volume
1.7×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
JCISPY benchmark
Ask FN2 about JCI FY2026 Q4
Transcript, numbers and history already loaded
What drove JCI's +5.7% move after FY2026 Q4 earnings?What changed in JCI's guidance and outlook in FY2026 Q4?Give me the bull and bear case for JCI after FY2026 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The emphasis shifted from the prior quarter's FY2026 guidance raise to executing FY2027 plans: a $900 million capex program, record backlog conversion, restructuring savings, and expanded thermal-management capacity.
Guidance delta
FY2027 guidance was maintained at 11%-12% organic revenue growth and adjusted EPS of $6.15-$6.30. Planned FY2027 capex is $900 million.
Key takeaways
- FY2026 included 8% organic revenue growth, 37% adjusted EPS growth, and 103% free-cash-flow conversion.
- The backlog reached a record $23 billion, with data-center and mission-critical demand central to the outlook.
- Management plans $900 million of FY2027 capex and is targeting $600 million of annualized restructuring savings by FY2029.
Management priorities
- Expand manufacturing, innovation, and digital/AI capabilities through FY2027 capex.
- Scale cooling distribution units, cold plates, and modular data-center offerings with partners.
- Execute restructuring, bolt-on acquisitions, and AI-enabled productivity initiatives.
Follow JCI with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$155.88Current
$58Low
$115.66Average
$190High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Neutral | Neutral | Maintain | Oct 15, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 14, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 12, 2026 |
| B of A Securities | Buy | Buy | Maintain | Oct 8, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 2, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Aug 14, 2026 |
| UBS | Buy | Buy | Maintain | Jun 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 7, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 6, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 7, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 7, 2025 |
| Jefferies | Hold | Buy | Downgrade | Jul 24, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Jun 20, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | May 12, 2025 |
| Melius Research | Hold | Buy | Downgrade | Jan 28, 2025 |
| HSBC | Hold | Buy | Downgrade | Jan 31, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Dec 13, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 4, 2022 |
| OTR Global | Positive | Mixed | Upgrade | Apr 27, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Dec 9, 2020 |
| CFRA | Buy | Buy | Maintain | May 1, 2020 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 9, 2020 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Feb 19, 2019 |
| Argus | Buy | Hold | Upgrade | Aug 21, 2018 |
| Susquehanna | Neutral | Positive | Downgrade | Nov 15, 2017 |
| Vertical Group | Hold | Buy | Downgrade | Nov 10, 2017 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 23, 2017 |
| Macquarie | Outperform | Outperform | Maintain | Sep 8, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 2, 2015 |
| Nomura | Buy | Buy | Maintain | Oct 2, 2015 |
| Ascendiant Capital | Buy | Buy | Maintain | Dec 23, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Feb 19, 2014 |
| Lazard | Buy | Neutral | Upgrade | May 13, 2013 |
| Credit Agricole | Buy | Outperform | Maintain | Mar 14, 2013 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 1, 2012 |
| Stifel | Buy | Buy | Maintain | Nov 1, 2012 |
| Needham | Hold | Buy | Downgrade | Nov 1, 2012 |
| Sterne Agee | Neutral | Neutral | Maintain | Jul 24, 2012 |
| Bank of America | Buy | Buy | Maintain | Jul 19, 2012 |
| Wunderlich Securities | Buy | Buy | Maintain | Jul 6, 2012 |
| Wunderlich | Buy | Buy | Maintain | Jul 6, 2012 |
| Guggenheim | Buy | Buy | Maintain | Mar 7, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $155.88. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $165 | $152.44 | +5.9% | Oct 15, 2026 |
| Wells Fargo | Analyst unavailable | $186 | $145.36 | +19.3% | Sep 24, 2026 |
| Morgan Stanley | Analyst unavailable | $180 | $138.46 | +15.5% | Sep 2, 2026 |
| Bernstein | Analyst unavailable | $190 | $152.36 | +21.9% | Aug 14, 2026 |
| Argus Research | John Eade | $175 | $154.55 | +12.3% | Aug 7, 2026 |
| Bernstein | Analyst unavailable | $176 | $147.75 | +12.9% | Jun 9, 2026 |
| Morgan Stanley | Chris Snyder | $175 | $144.05 | +12.3% | Jun 9, 2026 |
| Wolfe Research | Analyst unavailable | $171 | $141.99 | +9.7% | Jun 3, 2026 |
| UBS | Amit Mehrotra | $180 | $141.26 | +15.5% | Jun 2, 2026 |
| RBC Capital | Analyst unavailable | $154 | $139.12 | -1.2% | May 7, 2026 |
| Barclays | Julian Mitchell | $144 | $143.14 | -7.6% | May 7, 2026 |
| Morgan Stanley | Christopher Snyder | $140 | $134.99 | -10.2% | Mar 11, 2026 |
| RBC Capital | Deane Dray | $140 | $131.97 | -10.2% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $130 | $131.39 | -16.6% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $154 | $129.49 | -1.2% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $132 | $129.49 | -15.3% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $136 | $129.49 | -12.8% | Feb 5, 2026 |
| Morgan Stanley | Analyst unavailable | $130 | $111.51 | -16.6% | Jan 13, 2026 |
| Melius Research | Scott Davis | $148 | $113.95 | -5.1% | Jan 7, 2026 |
| Barclays | Analyst unavailable | $125 | $113.95 | -19.8% | Jan 7, 2026 |
| Goldman Sachs | Analyst unavailable | $142 | $122.25 | -8.9% | Nov 6, 2025 |
| UBS | Amit Mehrotra | $124 | $123 | -20.5% | Nov 6, 2025 |
| Barclays | Julian Mitchell | $90 | $95.28 | -42.3% | May 14, 2025 |
| Wells Fargo | Joe O’Dea | $100 | $91.68 | -35.8% | May 8, 2025 |
| Barclays | Analyst unavailable | $85 | $80.07 | -45.5% | Mar 10, 2025 |
| Wells Fargo | Joesph O'Dea | $92 | $79.17 | -41.0% | Jan 7, 2025 |
| Argus Research | John Eade | $88 | $79.25 | -43.5% | Dec 20, 2024 |
| Bank of America Securities | Andrew Obin | $80 | $68.6 | -48.7% | Sep 10, 2024 |
| Morgan Stanley | Chris Snyder | $85 | $69.38 | -45.5% | Sep 6, 2024 |
| RBC Capital | Sector Perform | $69 | $67.82 | -55.7% | Aug 14, 2024 |
| RBC Capital | Deane Dray | $61 | $71.03 | -60.9% | Aug 1, 2024 |
| Barclays | Julian Mitchell | $62 | $68.19 | -60.2% | Jun 21, 2024 |
| Barclays | Julian Mitchell | $61 | $65.13 | -60.9% | Apr 2, 2024 |
| Citigroup | Andrew Kaplowitz | $58 | $56.08 | -62.8% | Dec 11, 2023 |
| Morgan Stanley | Joshua Pokrzywinski | $73 | $58.51 | -53.2% | May 5, 2023 |
| Oppenheimer | Analyst unavailable | $72 | $66.36 | -53.8% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $72 | $65.02 | -53.8% | Jan 5, 2023 |
| Barclays | Analyst unavailable | $75 | $65.65 | -51.9% | Jan 5, 2023 |
| Citigroup | Analyst unavailable | $68 | $65.77 | -56.4% | Dec 9, 2022 |
| Deutsche Bank | Analyst unavailable | $74 | $66.98 | -52.5% | Dec 5, 2022 |
| J.P. Morgan | Analyst unavailable | $70 | $67.63 | -55.1% | Dec 2, 2022 |
| Morgan Stanley | Analyst unavailable | $62 | $54.89 | -60.2% | Sep 1, 2022 |
| Morgan Stanley | Analyst unavailable | $61 | $55.53 | -60.9% | Aug 8, 2022 |
| Oppenheimer | Analyst unavailable | $63 | $55.1 | -59.6% | Aug 8, 2022 |
| Jefferies | Stephen Volkmann | $65 | $50.34 | -58.3% | Jul 26, 2022 |
| Mizuho Securities | Analyst unavailable | $65 | $47.03 | -58.3% | Jul 18, 2022 |
| Barclays | Analyst unavailable | $60 | $47.67 | -61.5% | Jul 8, 2022 |
| Morgan Stanley | Analyst unavailable | $54 | $47.82 | -65.4% | Jul 7, 2022 |
| Wells Fargo | Analyst unavailable | $60 | $48.44 | -61.5% | Jun 29, 2022 |
| Goldman Sachs | Analyst unavailable | $62 | $47.44 | -60.2% | Jun 23, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $59 | $55 | -62.2% | Jun 7, 2022 |
| Barclays | Analyst unavailable | $65 | $50.89 | -58.3% | May 24, 2022 |
| RBC Capital | Analyst unavailable | $61 | $54.59 | -60.9% | May 5, 2022 |
| Credit Suisse | John Walsh | $73 | $54.83 | -53.2% | May 5, 2022 |
| Morgan Stanley | Analyst unavailable | $71 | $54.84 | -54.5% | May 5, 2022 |
| Barclays | Julian Mitchell | $80 | $66.2 | -48.7% | Apr 5, 2022 |
| Mizuho Securities | Brett Linzey | $88 | $68.88 | -43.5% | Feb 3, 2022 |
| Jefferies | Stephen Volkmann | $90 | $73.39 | -42.3% | Jan 24, 2022 |
| Cowen & Co. | Gautam Khanna | $86 | $80.87 | -44.8% | Dec 31, 2021 |
| UBS | Markus Mittermaier | $92 | $77.03 | -41.0% | Dec 14, 2021 |
| Citigroup | Andrew Kaplowitz | $81 | $73.75 | -48.0% | Nov 8, 2021 |
| Oppenheimer | Noah Kaye | $86 | $74.62 | -44.8% | Sep 9, 2021 |
| HSBC | Puneet Garg | $66 | $70.41 | -57.7% | Aug 4, 2021 |
| Wolfe Research | Nigel Coe | $83 | $69.75 | -46.8% | Jul 12, 2021 |
| Goldman Sachs | Joe Ritchie | $83 | $67.72 | -46.8% | Jun 30, 2021 |
| Argus Research | John Eade | $72 | $63.75 | -53.8% | May 6, 2021 |
Track every rating change on JCI the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationJohnson Controls International plc, together with its subsidiaries, engages in engineering, manufacturing, commissioning, and retrofitting building products and systems in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company designs, manufactures, sells, installs, and services heating, ventilating, air conditioning, controls, building management, refrigeration, integrated electronic security, integrated fire detection and suppression systems, and digital solutions. It also provides energy solutions and technical services, including inspection, scheduled maintenance, and repair and replacement of mechanical and control systems, as well as data-driven building solutions. It sells its products and services to commercial, residential security, institutional, industrial, data center, marine, and governmental customers. Johnson Controls International plc was incorporated in 1885 and is based in Cork, Ireland.
Historical context
All JCI earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ECL Ecolab Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +0.8% | Ecolab Sustains Growth While Investing in High-Tech Capacity |
| FCX Freeport-McMoRan Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +1.4% | Freeport highlights Grasberg ramp-up and copper growth plans as sales guidance is trimmed |
| NUE Nucor Corporation | FY2026 Q3 · Calendar Q4 2026 | -0.7% | +5.9% | Nucor: Record shipments support strong Q3; CapEx set to moderate |
| SHW The Sherwin-Williams Company | FY2026 Q3 · Calendar Q4 2026 | — | -2.6% | Sherwin-Williams Q3: Growth, Costs and 2027 Savings |
| CX CEMEX, S.A.B. de C.V. | FY2026 Q3 · Calendar Q4 2026 | +12.0% | -0.1% | CEMEX sustains growth while shifting focus to efficiency and asset pruning |
Latest beats and misses
Who reports nextBeat on EPS
- HIGFY2026 Q3 · October 26, 2026+10.4% EPS-1.8% move
- CLSFY2026 Q3 · October 26, 2026+12.6% EPS+12.1% move
- CINFFY2026 Q3 · October 26, 2026+39.5% EPS+2.3% move
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
Missed on EPS
- BROFY2026 Q3 · October 26, 2026-1.8% EPS-5.0% move
- PSA-PLFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PNFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-POFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PKFY2026 Q3 · October 26, 2026-32.1% EPS— move
- PSA-PGFY2026 Q3 · October 26, 2026-32.1% EPS— move
Get the JCI recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-27T16:08:26.873678+00:00
- FN2 earnings calendar · 2026-10-27T01:23:15.065758+00:00
- Polygon adjusted daily market bars · 2026-10-28T00:00:44.811780+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-28T00:00:44.809150+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-28. For educational purposes only; not investment advice.